News from Novo

Here's how three of the market's biggest decliners can bounce back

Novo Nordisk shares fall 5.4% after latest trial results for its next-generation weight loss drug

Novo Slashes Wegovy Price, Undercutting Its Most Bitter Rival

Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy

The Spectacular Dive That Saw Hims Stock Lose 45% Over Five Days

Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again

Shares of Hims & Hers plunge after bullish outlook on semaglutide

Prediction: These Could Be the Best-Performing Value Stocks Through 2030

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

Cacá Diegues, renowned Brazilian filmmaker and leading figure in Cinema Novo, dies at 84

Volvo Cars will not pay Northvolt for battery joint venture stake, it says

Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs

Novo Pops After Ozempic Beats. But Supply Shortages Expected.

No plan to prop up global health, Novo Nordisk Foundation says, as Trump freezes US aid

Portugal says Novo Banco IPO likely to be for stake of up to 30%

Ozempic maker Novo Nordisk failed to disclose millions it paid to healthcare groups - watchdog

Novo Nordisk shares pop 9% on early-stage weight loss drug trial results

Novo Nordisk’s mega-dose version of semaglutide lost more body weight than usual in a large-scale trial

Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs